海藻生物制药推动海洋强国建设研究进展

Research Progress of Marine-algae Biopharmaceutical Promoting the Construction of Maritime Power

海藻细胞内含有丰富的多糖,是未来海洋生物医药研究领域的前沿热点。目前,海藻多糖积累主要聚焦于大型海藻,与大型海藻相比,海洋微藻具有种类繁多、操作简单、测定精准等优势,是亟待挖掘的有潜力的海洋生物医药的种质资源。文章从药用海藻资源的开发、药用海藻资源的培养、海藻生物制药的环境保障分析入手,分析海洋生物制药存在的瓶颈,挖掘切实可行的解决途径,提出“海洋微藻生物制药全链条”新理念,为助推海洋强国建设、提升海洋生物医药的经济效益和市场竞争力奠定基础。

The rich polysaccharides in marine algae cells are the frontier hotspots in the field of marine biomedicine in the future.At present,the accumulation of polysaccharides in marine algae mainly focuses on macroalgae.Compared with macroalgae,marine microalgae have the advantages of wide variety,simple operation,and accurate measurement.They are potential marine biomedical germplasm resources that need to be tapped urgently.This paper started with the development of medicinal marine algae resources,the cultivation of medicinal marine algae,and the environmental assurance analysis of marine biopharmaceuticals,to find out the bottlenecks existing in marine biopharmaceuticals,and to explore feasible solutions.The new concept of“The whole chain of marine microalgae biopharmaceuticals”would lay the foundation for boosting maritime power and enhancing the economic benefits and market competitiveness of marine biomedicine.